C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2011
06/09/2011	US20110136666 Chemical compounds
06/09/2011	US20110135691 Immunomodulation by iap inhibitors
06/09/2011	US20110135668 Compounds and compositions as protein kinase inhibitors
06/09/2011	US20110135650 Morpholinone compounds as factor ixa inhibitors
06/09/2011	US20110135604 Antiviral compounds
06/09/2011	US20110135600 Bicyclic traizole derivatives for treating of tumors
06/09/2011	US20110135599 Antiviral compounds
06/09/2011	US20110135594 Oxindolyl inhibitor compounds
06/09/2011	DE102009056636A1 Raltegravir-Polymorphe Raltegravir polymorphs
06/09/2011	CA2781521A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/09/2011	CA2780522A1 Insecticidal compounds based on isoxazoline derivatives
06/08/2011	EP2330158A1 Lighting cover
06/08/2011	EP2330106A1 Insecticidal isoxazolines
06/08/2011	EP2330105A1 Heteroaryl urea derivatives useful for inhibiting CHK1
06/08/2011	EP2328893A1 Triazole compounds that modulate hsp90 activity
06/08/2011	EP2328880A2 6-substituted benzoxazines as 5-ht-5a receptor antagonists
06/08/2011	EP2328867A1 Heterocyclic gpcr agonists
06/08/2011	EP2207770B1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
06/08/2011	EP2064185B1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
06/08/2011	EP1817312B1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
06/08/2011	EP1812426B1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
06/08/2011	EP1479397B1 2,4,6-triamino-1,3,5-triazine derivative
06/08/2011	CN1926097B Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors
06/08/2011	CN1816544B Immunosuppressant compounds and compositions
06/08/2011	CN102089301A Piperidine gpcr agonists
06/08/2011	CN102089300A Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
06/08/2011	CN102089299A Piperidinyl gpcr agonists
06/08/2011	CN102089298A Heterocyclic gpcr agonists
06/08/2011	CN102089297A Novel 1,2,4 oxadiazole compounds and methods of use thereof
06/08/2011	CN102086211A Aromatic heterocyclic compounds serving as protein kinase inhibitor
06/08/2011	CN102086194A Synthesis method of furazolidone
06/08/2011	CN101468987B Method for splitting 2-heterocycle substituted dihydropyrimidine racemic compound
06/08/2011	CN101115718B N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands
06/08/2011	CN101080404B Pyrimidinylisoxazol derivative
06/07/2011	US7956196 the major cause of lower respiratory tract illness during infancy and childhood
06/07/2011	US7956194 Microbiocidal (E.G. fungicidal) 1,2,3-triazole derivatives
06/07/2011	US7956084 Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2
06/07/2011	US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/07/2011	US7956060 Pyrimidine derivative compound
06/07/2011	US7956055 Substituted gamma lactams as therapeutic agents
06/07/2011	US7956054 Dual-acting pyrazole antihypertensive agents
06/07/2011	US7956051 Therapeutic amides and related compounds
06/07/2011	CA2562130C 2-propene-1-ones as hsp 70 inducers
06/07/2011	CA2551141C Derivatives of n-(1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
06/07/2011	CA2505545C Indolyl derivatives
06/03/2011	WO2011066544A2 Deuterated compounds useful for treating neurodegenerative diseases
06/03/2011	WO2011066482A2 Chiral synthesis of isoxazolines, isoxazoline compounds, and uses thereof
06/03/2011	WO2011066183A1 Novel spiropiperidine compounds
06/03/2011	WO2011065530A1 Organic luminous element
06/03/2011	WO2011065402A1 Indole compound and pharmaceutical use thereof
06/03/2011	WO2011063764A1 Azilsartan organic amine salts, preparation method and use thereof
06/03/2011	WO2011042473A3 Estrogen receptor ligands
06/03/2011	WO2010135429A8 Compositions for modulating a kinase cascade and methods of use thereof
06/03/2011	CA2782224A1 Azilsartan organic amine salts, preparation method and use thereof
06/03/2011	CA2781660A1 Indole compound and pharmaceutical use thereof
06/03/2011	CA2781292A1 Novel spiropiperidine compounds
06/02/2011	US20110130433 Hepatitis C Virus Inhibitors
06/02/2011	US20110130407 Isoquinolinone derivatives as nk3 antagonists
06/02/2011	US20110130401 New chemical compounds
06/02/2011	US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity
06/02/2011	US20110130398 Spiroindolinone pyrrolidines
06/02/2011	US20110130397 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
06/02/2011	US20110130394 Pharmaceutical compounds
06/02/2011	US20110130393 Inhibitors of janus kinases
06/02/2011	US20110130386 Dna-pk inhibitors
06/02/2011	US20110130381 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
06/02/2011	US20110130380 Heteroaryl Kinase Inhibitors
06/02/2011	US20110130377 Substituted aryloxazoles and their use
06/02/2011	US20110130286 Piperazine Compounds with Herbicidal Effect
06/02/2011	US20110129678 Photochromic compounds and compositions
06/01/2011	EP2327733A1 Non-Crystallising Bis-Oxazolidines
06/01/2011	EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
06/01/2011	EP2327690A1 Tricyclic compound
06/01/2011	EP2326640A1 Pyrrole carboxylic acid derivatives as antibacterial agents
06/01/2011	EP2326633A1 Compounds for the treatment of hepatitis c
06/01/2011	EP2326629A1 Sulfone compounds which modulate the cb2 receptor
06/01/2011	EP2326627A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
06/01/2011	EP2326625A1 Benzazepine derivatives and their use as hstamine h3 antagonists
06/01/2011	EP2326623A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
06/01/2011	EP1981854B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/01/2011	CN102083825A FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
06/01/2011	CN102083824A Method of treating cancer using a cMET and AXL inhibitor and an ErbB inhibitor
06/01/2011	CN102083820A Pyrrolidin-3-ylmethyl-amine as orexin antagonists
06/01/2011	CN102083819A Novel phenylpyrazinones as kinase inhibitors
06/01/2011	CN102083812A Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia
06/01/2011	CN102083810A Activator for peroxisome proliferator-activated receptor
06/01/2011	CN102083805A 4,5-dihydro-oxazol-2-yl derivatives
06/01/2011	CN102083804A 5-phenyl-isoxazole-3-carboxamides modulating HSP90 with antitumoral activities
06/01/2011	CN102083800A Heteroaryl compounds and uses thereof
06/01/2011	CN102083797A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
06/01/2011	CN102083794A Urea compounds as gamma secretase modulators
06/01/2011	CN102083793A Protease inhibitors
06/01/2011	CN102079730A Derivatives containing 2, 5-substituted heterocyclic radical sulphone and synthesis method and application thereof
05/2011
05/31/2011	US7951955 Antiviral agents
05/31/2011	US7951940 Substituted indole compounds having NOS inhibitory activity
05/31/2011	US7951846 pH-sensitive polymeric micelles for drug delivery
05/31/2011	US7951836 Substituted phenyl methanone derivatives
05/31/2011	US7951830 Compounds effecting glucokinase
05/31/2011	US7951827 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
05/31/2011	US7951825 Hetero compound

1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 647